Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, et al. Clinical spectrum of pheochromocytoma. J Am Coll Surg. 2009;209:727–32.

PubMed  Google Scholar 

Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.

CAS  PubMed  Google Scholar 

Bholah R, Bunchman TE. Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr. 2017;5:155.

PubMed  PubMed Central  Google Scholar 

Segen JC. The dictionary of modern medicine. 1992.

Soltani A, Pourian M, Davani BM. Does this patient have pheochromocytoma? a systematic review of clinical signs and symptoms. J Diabetes Metab Disord. 2015;15:6.

PubMed  Google Scholar 

Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med. 1987;147:1289–93.

CAS  PubMed  Google Scholar 

Anderson GH Jr., Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–15.

PubMed  Google Scholar 

Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193–202.

PubMed  Google Scholar 

Danielson M, Dammström B. The prevalence of secondary and curable hypertension. Acta Med Scand. 1981;209:451–5.

CAS  PubMed  Google Scholar 

Cohen DL, Fraker D, Townsend RR. Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge. Ann N Y Acad Sci. 2006;1073:47–51.

PubMed  Google Scholar 

Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–9.

CAS  PubMed  Google Scholar 

Giles T. Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens Suppl. 2005;23:S35–39.

CAS  PubMed  Google Scholar 

Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22:273–80.

CAS  PubMed  Google Scholar 

Fagard RH, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease. Blood Press Monit. 2008;13:325–32.

PubMed  Google Scholar 

Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192–204.

PubMed  Google Scholar 

Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of masked uncontrolled hypertension. Hypertension. 2018;72:862–9.

CAS  PubMed  Google Scholar 

Baumgart P, Kamp J. Accuracy of the SpaceLabs Medical 90,217 ambulatory blood pressure monitor. Blood Press Monit. 1998;3:303–7.

CAS  PubMed  Google Scholar 

Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73:e35–e66.

CAS  PubMed  Google Scholar 

Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71:e13–e115.

CAS  PubMed  Google Scholar 

Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23:505–11.

CAS  PubMed  Google Scholar 

Dabrowska B, Dabrowski A, Pruszczyk P, Skrobowski A, Wocial B. Heart rate variability in pheochromocytoma. Am J Cardiol. 1995;76:1202–4.

CAS  PubMed  Google Scholar 

Zelinka T, Strauch B, Petrák O, Holaj R, Vranková A, Weisserová H, et al. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens. 2005;23:2033–9.

CAS  PubMed  Google Scholar 

Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens. 2004;22:1691–7.

PubMed  Google Scholar 

Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36:901–6.

CAS  PubMed  Google Scholar 

Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098.

PubMed  PubMed Central  Google Scholar 

Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11:1133–7.

CAS  PubMed  Google Scholar 

Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation. 2000;102:1536–41.

CAS  PubMed  Google Scholar 

Tsujimoto G, Honda K, Hoffman BB, Hashimoto K. Desensitization of postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma. Circ Res. 1987;61:86–98.

CAS  PubMed  Google Scholar 

Streeten DH, Anderson GH Jr. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens. 1996;9:760–9.

CAS  PubMed  Google Scholar 

Minami J, Todoroki M, Ishimitsu T, Matsuoka H. Changes in heart rate variability before and after surgery in patients with pheochromocytoma. Auton Neurosci. 2004;111:144–6.

PubMed  Google Scholar 

Bisogni V, Petramala L, Oliviero G, Bonvicini M, Mezzadri M, Olmati F, et al. Analysis of short-term blood pressure variability in pheochromocytoma/paraganglioma patients. Cancers. 2019;11:658.

CAS  PubMed  PubMed Central  Google Scholar 

Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med. 1979;301:682–6.

CAS  PubMed  Google Scholar 

Engelman K, Sjoerdsma A. A new test for pheochromocytoma. Jama. 1964;189:705-9.